melatonin has been researched along with Demyelinating Diseases in 12 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Conflicting results on melatonin synthesis in multiple sclerosis (MS) have been reported due to variabilities in patient lifestyles, which are not considered when supplementing melatonin." | 8.31 | Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis. ( Ghareghani, M; Laflamme, N; Pons, V; Rivest, S; Zibara, K, 2023) |
| "Multiple sclerosis is a central nervous system demyelinating disease." | 5.29 | Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis. ( Constantinescu, CS, 1995) |
| "Conflicting results on melatonin synthesis in multiple sclerosis (MS) have been reported due to variabilities in patient lifestyles, which are not considered when supplementing melatonin." | 4.31 | Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis. ( Ghareghani, M; Laflamme, N; Pons, V; Rivest, S; Zibara, K, 2023) |
| " Previous studies have identified that melatonin improves cognitive dysfunction in animal models." | 3.88 | Melatonin attenuates scopolamine-induced cognitive impairment via protecting against demyelination through BDNF-TrkB signaling in the mouse dentate gyrus. ( Ahn, JH; Chen, BH; Hwang, IK; Kang, IJ; Kim, H; Kim, YM; Lee, CH; Lee, JC; Lee, TK; Park, JH; Song, M; Won, MH; Yan, BC, 2018) |
| "Melatonin also reduced reactive gliosis." | 1.38 | Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia. ( Alonso-Alconada, D; Alvarez, A; Hilario, E; Lacalle, J, 2012) |
| "Multiple sclerosis is a central nervous system demyelinating disease." | 1.29 | Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis. ( Constantinescu, CS, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ghareghani, M | 1 |
| Pons, V | 1 |
| Laflamme, N | 1 |
| Zibara, K | 1 |
| Rivest, S | 1 |
| Labunets, IF | 1 |
| Rodnichenko, AE | 1 |
| Huang, CT | 1 |
| Chen, SH | 1 |
| Chang, CF | 1 |
| Lin, SC | 1 |
| Lue, JH | 1 |
| Tsai, YJ | 1 |
| Chen, BH | 1 |
| Park, JH | 1 |
| Lee, TK | 1 |
| Song, M | 1 |
| Kim, H | 1 |
| Lee, JC | 1 |
| Kim, YM | 1 |
| Lee, CH | 1 |
| Hwang, IK | 1 |
| Kang, IJ | 1 |
| Yan, BC | 1 |
| Won, MH | 1 |
| Ahn, JH | 1 |
| Vakilzadeh, G | 1 |
| Khodagholi, F | 1 |
| Ghadiri, T | 1 |
| Ghaemi, A | 1 |
| Noorbakhsh, F | 1 |
| Sharifzadeh, M | 1 |
| Gorji, A | 1 |
| Alonso-Alconada, D | 1 |
| Alvarez, A | 1 |
| Lacalle, J | 1 |
| Hilario, E | 1 |
| Bloom, CM | 1 |
| Anch, AM | 1 |
| Dyche, JS | 1 |
| Sandyk, R | 4 |
| Dann, LC | 1 |
| Constantinescu, CS | 1 |
3 reviews available for melatonin and Demyelinating Diseases
| Article | Year |
|---|---|
Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields.
Topics: Antineoplastic Agents; Brain; Demyelinating Diseases; Electromagnetic Fields; Female; Humans; Interf | 1995 |
Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields.
Topics: Adult; Axons; Brain; Demyelinating Diseases; Electromagnetic Phenomena; Female; Humans; Male; Melato | 1995 |
Successful treatment of multiple sclerosis with magnetic fields.
Topics: Brain; Brain Diseases; Chronic Disease; Demyelinating Diseases; Electromagnetic Fields; Female; Huma | 1992 |
9 other studies available for melatonin and Demyelinating Diseases
| Article | Year |
|---|---|
Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis.
Topics: Animals; Cell Differentiation; Demyelinating Diseases; Disease Models, Animal; Hydrocortisone; Melat | 2023 |
[Melatonin effects in young and aged mice with toxic cuprizone-induced model of demyelination.]
Topics: Animals; Antioxidants; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Melatonin; Mice; M | 2019 |
Melatonin reduces neuropathic pain behavior and glial activation through MT
Topics: Animals; Demyelinating Diseases; Lysophosphatidylcholines; Male; Melatonin; Microinjections; Neuralg | 2020 |
Melatonin attenuates scopolamine-induced cognitive impairment via protecting against demyelination through BDNF-TrkB signaling in the mouse dentate gyrus.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Demyelin | 2018 |
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Topics: Animals; Antioxidants; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Dose-Response Rela | 2016 |
Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Apoptosis; Biomarkers; Brain; Brain Infarction; Demyelinating Diseases; D | 2012 |
Behavioral effects of chronic melatonin and pregnenolone injections in a myelin mutant rat (taiep).
Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Gait; Gait Disorders, Neurologic; Melatonin | 2002 |
Demyelination as an epiphenomenon in multiple sclerosis.
Topics: Animals; Demyelinating Diseases; Evoked Potentials; Humans; Magnetics; Melatonin; Models, Neurologic | 1993 |
Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis.
Topics: Animals; Autoimmune Diseases; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; H | 1995 |